As chaperonas moleculares atuam no enovelamento de proteínas, montagem de complexos, prevenção/recuperação de proteínas de agregados e encaminhamento de proteínas mal enoveladas para depuração. As Hsp90 são chaperonas moleculares que atuam estabilizando proteínas relacionadas a vias de sinalização, crescimento celular, processos transcricionais e traducionais, estabilidade do genoma, entre outras, sendo essencial para a viabilidade celular. Em protozoários do gênero Leishmania, as Hsp90 são imprescindíveis no desenvolvimento, adaptação e transformação celular. Estes fatores fazem das Hsp90 alvos potenciais para o tratamento de patologias, como a leishmaniose, uma doença tropical negligenciada. As Hsp90 são homodímeros flexíveis onde cada protômero é dividido em três domínios denominados N, M e C. As Hsp90 possuem um ciclo conformacional associado ao seu ciclo funcional e sua baixa atividade ATPásica, o qual é direcionado e regulado por proteínas auxiliares, as co-chaperonas. A co-chaperona Aha1 atua estimulando a atividade ATPásica da Hsp90, participando da maturação de proteínas quinase e receptores de hormônios. O objetivo deste trabalho foi caracterizar estruturalmente a proteína Aha1 de L. braziliensis (LbAha1) e seu mecanismo de interação com a Hsp90 desse organismo (LbHsp90). A LbAha1 é formada por dois domínios, LbAha1N e LbAha1C, conectados entre si por um linker flexível. Experimentos de identificação in vivo mostraram que a LbAha1 e LbHsp90 são proteínas cognatas. A LbAha1 e as construções de seus domínios (LbAha1N e LbAha1C) recombinantes foram obtidas puras e enoveladas. A LbAha1 é estruturada em dois domínios com diferentes estabilidades, que não interagem entre si e se enovelam independentemente, porém influenciam-se reciprocamente. Em solução, a LbAha1 se comporta como um monômero alongado e possui notável flexibilidade, com dimensão suficiente para interagir com os domínios N e M da LbHsp90. A análise da interação entre a LbAha1 e LbHsp90 revelou que a associação destas proteínas é dirigida entalpicamente, ocorrendo através de interações eletrostáticas e com estequiometria de 2 moléculas de LbAha1 por dímero de LbHsp90. O mapeamento de regiões envolvidas na interação indicou que o domínio LbAha1N e o domínio M da LbHsp90 compõem o cerne da interação e somente a LbAha1 íntegra é capaz de encaminhar a LbHsp90 para um estado fechado. Experimentos de cinética enzimática mostraram que somente a LbAha1 íntegra estimula a atividade ATPásica da LbHsp90 por meio de um mecanismo cooperativo positivo. Assim, é proposto que a conexão entre os domínios da LbAha1, via linker, é essencial para o direcionamento da LbHsp90 para um estado conformacional fechado e competente na hidrólise de ATP. / Molecular chaperones play a role in protein folding, complex assembly, prevention/recover of proteins from aggregates and targeting misfolded proteins to depuration. Hsp90 molecular chaperones work stabilizing proteins related to signaling pathways, cell growth, transcription and translation processes, genome stability, among others, and are essential to cell viability. In protozoa of the genus Leishmania, Hsp90s are indispensable for cell developing, adaptation and transformation. These factors make Hsp90s potential targets for pathologies treatment, such as leishmaniasis, a neglected tropical disease. Hsp90s are flexible homodimers and each protomer is divided into three domains named N, M and C. Hsp90s have a conformational cycle associated to its functional cycle and low ATPase activity, which is directed and regulated by auxiliary proteins, so-called cochaperones. Aha1 co-chaperone stimulates Hsp90 ATPase activity, participating on protein kinase and hormone receptors maturation. This work aimed to characterize the structure of the Aha1 from L. braziliensis (LbAha1) and its mechanism of interaction with the Hsp90 from the same organism (LbHsp90). LbAha1 is formed by two domains, LbAha1N and LbAha1C, connected to each other by a flexible linker. In vivo experiments identified LbAha1 and LbHsp90 as cognate proteins. Recombinant LbAha1 and its domains construct (LbAha1N and LbAha1C) were obtained pure and folded. LbAha1 is divided into two domains with dissimilar stabilities and they do not interact to each other. In spite of this they fold independently and influence each other reciprocally. LbAha1 behaves as an elongated monomer in solution and has a remarkable flexibility, with sufficient dimension to interact to LbHsp90 N and M domains. The analysis of the LbAha1-LbHsp90 interaction revealed that the association between these two proteins is enthalpically driven, occurring through electrostatic interactions in a stoichiometry of 2 LbAha1 molecules per LbHsp90 dimer. Domain mapping experiments indicated that LbAha1N and LbHsp90 M domains compose the core of the interaction and only full length LbAha1 is able to direct LbHsp90 toward a closed state. Enzyme kinetics experiments showed that only full length LbAha1 stimulates LbHsp90 ATPase activity through a positive cooperative mechanism. Thus, it is proposed that the connection between the LbAha1 domains, via linker, is essential to direct the LbHsp90 toward a closed and ATPase-competent conformational state.

A leishmaniose é uma enfermidade infecciosa causada por várias espécies de parasitas do gênero Leishmania e representa um dos principais problemas de saúde pública nos países subdesenvolvidos. No hospedeiro, a sobrevivência do protozoário causador dessa doença depende de uma classe especial de proteínas, as chaperonas moleculares ou proteínas de choque térmico como também são conhecidas. A função dessas proteínas é auxiliar no processo de enovelamento protéico, no transporte de proteínas entre as membranas e em muitas outras importantes funções celulares. Neste processo, as chaperonas moleculares são auxiliadas pelas suas co-chaperonas que desempenham função de destaque. Dentre as principais famílias de chaperonas moleculares temos as Hsp70 e as Hsp90 com suas respectivas co-chaperonas, as Hsp40 e a Aha1. O presente trabalho pretendeu inicialmente expressar e purificar as co-chaperonas moleculares Hsp40I e Hsp40II de L. braziliensis para realizar estudos de caracterização estrutural por meio das técnicas de dicroísmo circular e fluorescência. Contudo, a insolubilidade dessas proteínas, que pode ter sido causada pela presença de mutações nas sequências de DNA, motivou a caracterização de outra co-chaperona, a Aha1 de L. braziliensis (LbAha1). A LbAha1 foi expressa no sobrenadante celular e purificada por três etapas cromatográficas (troca aniônica, afinidade por íons cálcio e gel filtração). A análise da sequência de aminoácidos dessa proteína mostra que ela possui 9 resíduos de triptofano distribuídos nos dois domínios característicos da LbAha1. Estudos de desnaturação química por uréia, monitorados pelas técnicas de dicroísmo circular e fluorescência, mostram que os dois domínios da LbAha1 apresentam estabilidades diferentes. Os estudos estruturais realizados permitiram identificar as transições com o respectivo domínio. / Leishmaniasis is an infectious disease caused by several species of Leishmania species and represents major public health problems in developing countries. In the harborer, the survival of the parasite that cause this disease depends on a special class of proteins, molecular chaperones or heat shock proteins as they are also known. The function of these proteins is to assist in protein folding, transport of proteins and many other important cellular functions. In this process the molecular chaperones are helped by their co-chaperones that play a prominent role. Among the main families of molecular chaperones, there are Hsp70 and Hsp90 with their respective co-chaperones, Hsp40 and the Aha1. The present work, initially pretended to express and purify the molecular co-chaperones Hsp40I and Hsp40II of the L. braziliensis for structural characterization by spectroscopic techniques like fluorescence and circular dichroism. However, the insolubility of these proteins, possibly caused by the presence of mutations in their DNA sequences, led to the characterization of another co-chaperone, the Aha1 of the L. braziliensis. These proteins were expressed in the cell supernatant and purified by three chromatographic steps (anion exchange, affinity for calcium ions and gel filtration). The analysis of the DNA sequence of this protein shows that it has nine Trp residues distributed between the two domains and by urea denaturation studies monitored by fluorescence techniques and circular dichroism show that they have different stabilities.

As chaperonas moleculares atuam no enovelamento de proteínas, montagem de complexos, prevenção/recuperação de proteínas de agregados e encaminhamento de proteínas mal enoveladas para depuração. As Hsp90 são chaperonas moleculares que atuam estabilizando proteínas relacionadas a vias de sinalização, crescimento celular, processos transcricionais e traducionais, estabilidade do genoma, entre outras, sendo essencial para a viabilidade celular. Em protozoários do gênero Leishmania, as Hsp90 são imprescindíveis no desenvolvimento, adaptação e transformação celular. Estes fatores fazem das Hsp90 alvos potenciais para o tratamento de patologias, como a leishmaniose, uma doença tropical negligenciada. As Hsp90 são homodímeros flexíveis onde cada protômero é dividido em três domínios denominados N, M e C. As Hsp90 possuem um ciclo conformacional associado ao seu ciclo funcional e sua baixa atividade ATPásica, o qual é direcionado e regulado por proteínas auxiliares, as co-chaperonas. A co-chaperona Aha1 atua estimulando a atividade ATPásica da Hsp90, participando da maturação de proteínas quinase e receptores de hormônios. O objetivo deste trabalho foi caracterizar estruturalmente a proteína Aha1 de L. braziliensis (LbAha1) e seu mecanismo de interação com a Hsp90 desse organismo (LbHsp90). A LbAha1 é formada por dois domínios, LbAha1N e LbAha1C, conectados entre si por um linker flexível. Experimentos de identificação in vivo mostraram que a LbAha1 e LbHsp90 são proteínas cognatas. A LbAha1 e as construções de seus domínios (LbAha1N e LbAha1C) recombinantes foram obtidas puras e enoveladas. A LbAha1 é estruturada em dois domínios com diferentes estabilidades, que não interagem entre si e se enovelam independentemente, porém influenciam-se reciprocamente. Em solução, a LbAha1 se comporta como um monômero alongado e possui notável flexibilidade, com dimensão suficiente para interagir com os domínios N e M da LbHsp90. A análise da interação entre a LbAha1 e LbHsp90 revelou que a associação destas proteínas é dirigida entalpicamente, ocorrendo através de interações eletrostáticas e com estequiometria de 2 moléculas de LbAha1 por dímero de LbHsp90. O mapeamento de regiões envolvidas na interação indicou que o domínio LbAha1N e o domínio M da LbHsp90 compõem o cerne da interação e somente a LbAha1 íntegra é capaz de encaminhar a LbHsp90 para um estado fechado. Experimentos de cinética enzimática mostraram que somente a LbAha1 íntegra estimula a atividade ATPásica da LbHsp90 por meio de um mecanismo cooperativo positivo. Assim, é proposto que a conexão entre os domínios da LbAha1, via linker, é essencial para o direcionamento da LbHsp90 para um estado conformacional fechado e competente na hidrólise de ATP. / Molecular chaperones play a role in protein folding, complex assembly, prevention/recover of proteins from aggregates and targeting misfolded proteins to depuration. Hsp90 molecular chaperones work stabilizing proteins related to signaling pathways, cell growth, transcription and translation processes, genome stability, among others, and are essential to cell viability. In protozoa of the genus Leishmania, Hsp90s are indispensable for cell developing, adaptation and transformation. These factors make Hsp90s potential targets for pathologies treatment, such as leishmaniasis, a neglected tropical disease. Hsp90s are flexible homodimers and each protomer is divided into three domains named N, M and C. Hsp90s have a conformational cycle associated to its functional cycle and low ATPase activity, which is directed and regulated by auxiliary proteins, so-called cochaperones. Aha1 co-chaperone stimulates Hsp90 ATPase activity, participating on protein kinase and hormone receptors maturation. This work aimed to characterize the structure of the Aha1 from L. braziliensis (LbAha1) and its mechanism of interaction with the Hsp90 from the same organism (LbHsp90). LbAha1 is formed by two domains, LbAha1N and LbAha1C, connected to each other by a flexible linker. In vivo experiments identified LbAha1 and LbHsp90 as cognate proteins. Recombinant LbAha1 and its domains construct (LbAha1N and LbAha1C) were obtained pure and folded. LbAha1 is divided into two domains with dissimilar stabilities and they do not interact to each other. In spite of this they fold independently and influence each other reciprocally. LbAha1 behaves as an elongated monomer in solution and has a remarkable flexibility, with sufficient dimension to interact to LbHsp90 N and M domains. The analysis of the LbAha1-LbHsp90 interaction revealed that the association between these two proteins is enthalpically driven, occurring through electrostatic interactions in a stoichiometry of 2 LbAha1 molecules per LbHsp90 dimer. Domain mapping experiments indicated that LbAha1N and LbHsp90 M domains compose the core of the interaction and only full length LbAha1 is able to direct LbHsp90 toward a closed state. Enzyme kinetics experiments showed that only full length LbAha1 stimulates LbHsp90 ATPase activity through a positive cooperative mechanism. Thus, it is proposed that the connection between the LbAha1 domains, via linker, is essential to direct the LbHsp90 toward a closed and ATPase-competent conformational state.

L'îlot génomique pks code une machinerie de biosynthèse complexe synthétisant la colibactine, une génotoxine produite par certaines souches de Escherichia coli. Cette génotoxine induit des cassures double-brin de l'ADN sur les cellules eucaryotes in vitro et in vivo. La colibactine n'est pas une protéine, mais un métabolite secondaire de type polycétide/peptide non-ribosomal (PK/NRP). Des résultats préliminaires de l'équipe semblaient indiquer que certains gènes du core genome de E. coli seraient également impliqués dans la production de la colibactine. L'objectif de cette thèse était d'identifier les gènes non-essentiels de E. coli situés hors de l'îlot génomique pks impliqués dans la synthèse de colibactine, en construisant une banque de mutants par insertion de transposons. Ce criblage a permis d'identifier 29 gènes candidats, mais deux groupes de gènes ont été particulièrement étudiés dans la suite du projet : trois gènes codants des protéines chaperons, et trois gènes codant des enzymes impliquées dans le métabolisme des polyamines. Le premier projet a permis de montrer que la protéine chaperon HtpG (ou Hsp90Ec), homologue bactérien de la protéine de choc thermique eucaryote Hsp90, est requise pour la production de colibactine, mais aussi de yersiniabactine, un sidérophore (ou système bactérien de captation du fer) appartenant à la même famille chimique que la colibactine. De plus, la protéase ClpQ intervient de concert avec Hsp90Ec dans la production de colibactine et de yersiniabactine. Ces résultats confirment ainsi l'interconnexion entre la synthèse des deux facteurs de virulence de E. coli, la colibactine et la yersiniabactine. Enfin, l'analyse des effets de la mutation du gène htpG au cours d'une infection systémique chez l'animal, dans des modèles de sepsis et de méningite néonatale chez les rongeurs, démontre le rôle de la protéine de réponse au stress Hsp90Ec dans la virulence de E. coli. Le second projet a révélé que les polyamines sont impliquées dans la production de colibactine. L'étude du métabolisme des polyamines par une approche de microbiologie moléculaire a démontré que la spermidine est la polyamine nécessaire à la production de colibactine. Les résultats préliminaires de ce projet indiquent que la spermidine participerait à la régulation de l'expression de certains gènes de l'îlot génomique pks, et de fait modulerait la biosynthèse de colibactine. Des études complémentaires sont en cours pour élucider les mécanismes impliqués. Les résultats de cette thèse sont une illustration parfaite de l'intégration symbiotique d'un élément génétique mobile acquis au cours de l'évolution au sein du chromosome bactérien, grâce à plusieurs connexions bilatérales permettant la production de facteurs de virulence par E. coli. / The pks genomic island codes a complex biosynthetic assembly line that synthetizes the colibactin, a genotoxin produced by some strains of Escherichia coli. This genotoxin generates DNA double-strand breaks in eukaryotic cells both in vitro and in vivo. Colibactin is not a protein, but a secondary metabolite belonging to the chemical family of hybrid polyketide/nonribosomal peptide compounds. Preliminary results from our research team suggested that certain genes of the E. coli core genome (i.e. genes present in all strains of the species) could also be involved in the colibactin production. The main goal of this thesis was to identify non-essential E. coli genes located outside the pks island that are required for colibactin biosynthesis, with the screening of a transposon mutant library. This revealed 29 potential candidate genes, but the project focused specifically on two groups of genes: three genes encoding chaperone proteins, and three genes encoding enzymes involved in polyamines metabolism. The first project highlighted the role of the molecular chaperone HtpG (or Hsp90Ec), the bacterial homolog of eukaryotic heat shock protein 90, in the production of colibactin, but also yersiniabactin, a siderophore (i.e. a bacterial iron uptake system) that belongs to the same chemical family as colibactin. Furthermore, the ClpQ protease was involved in colibactin and yersiniabactin production in combination with Hsp90Ec. These results confirmed the interplay between the biosynthesis of two E. coli virulence factors, colibactin and yersiniabactin. Finally, analysis of the effects of htpG disruption during systemic infection in animals, using rodent models of sepsis and neonatal meningitis, demonstrated the role of the stress-responsive molecular chaperone Hsp90Ec in E. coli virulence. The second project revealed the involvement of polyamines in the biosynthesis of colibactin. A molecular microbiology approach demonstrated that spermidine was the polyamine required for colibactin production. Preliminary results suggested that spermidine could regulate the expression of some pks island genes, and therefore could modulate colibactin production. Further experiments are in progress to elucidate the molecular mechanisms involved in this regulation. Together, the results of this thesis perfectly illustrate the symbiotic integration of a mobile genetic element acquired during evolution into the bacterial chromosome, through several crosstalks allowing the production of virulence factors in E. coli.

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2015-12-30T14:31:06Z No. of bitstreams: 1 Antonio Luis de Oliveira Petersen Avaliação do 17-AAG... 2015.pdf: 4140982 bytes, checksum: b2369d43c8af2a304d5953f23f604a99 (MD5) / Approved for entry into archive by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2015-12-30T14:31:22Z (GMT) No. of bitstreams: 1 Antonio Luis de Oliveira Petersen Avaliação do 17-AAG... 2015.pdf: 4140982 bytes, checksum: b2369d43c8af2a304d5953f23f604a99 (MD5) / Made available in DSpace on 2015-12-30T14:31:22Z (GMT). No. of bitstreams: 1 Antonio Luis de Oliveira Petersen Avaliação do 17-AAG... 2015.pdf: 4140982 bytes, checksum: b2369d43c8af2a304d5953f23f604a99 (MD5) Previous issue date: 2015 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / A leishmaniose é uma doença endêmica no Brasil causada por parasitos protozoários do gênero Leishmania. A quimioterapia continua sendo a forma mais efetiva de tratamento com os antimoniais pentavalentes sendo usados há mais de 70 anos como a primeira linha de tratamento. O uso deste e de outros fármacos apresenta efeitos adversos graves, os esquemas terapêuticos empregados são desconfortáveis, além de relatos do aumento de casos de resistência. A proteína de choque térmico 90 (HSP90) é um membro da família das chaperonas presente em células eucarióticas e bactérias. Essa proteína é fundamental para o dobramento e estabilização de diferentes proteínas, chamadas genericamente de proteínas cliente. Essa chaperona vem sendo considerada um importante alvo molecular para o tratamento de diferentes doenças parasitárias. Nessa tese, o inibidor específico da atividade ATPásica da HSP90, o 17-allilamino-17-demethoxigeldanamicina (17- AAG) foi testado em parasitos do gênero Leishmania. Inicialmente, avaliamos o efeito em cultura axênica e observamos que o 17-AAG causa a morte desses parasitos em concentrações inferiores às necessárias para causar a morte de macrófagos. Observamos também que o tratamento com 17-AAG promove a morte intracelular dos parasitos em concentrações que variam de 25 a 500 nM nos tempos de 24 e 48 h, sendo também eficaz contra a forma amastigota em tempos mais tardios como 96 h de infecção. Os parasitos morrem independentemente da produção de moléculas microbicidas pelo macrófago, como superóxido e óxido nítrico, que tiveram sua produção reduzida em 61 e 58 %, respectivamente. O tratamento com 17-AAG também reduziu a produção de mediadores próinflamatórios como TNF-α, IL-6 e MCP-1 em 35, 35 e 92 %, respectivamente. Utilizando o modelo de camundongos BALB/c infectados por Leishmania braziliensis na orelha demonstramos que o tratamento com 17-AAG causou redução do tamanho da lesão cutânea em 0,5 mm e da carga parasitaria no local da infecção em 25 %, no entanto, não foi capaz de reduzir a carga parasitaria no linfonodo drenante. Análise por microscopia eletrônica de transmissão de macrófagos infectados e tratados com 17-AAG revelou alterações características de um processo autofágico com vacuolização do citoplasma e formação de vacúolos com dupla membrana, além da presença de figuras de mielina. Utilizando parasitos transgênicos observamos que 17-AAG induz um aumento de 30 % na formação de autofagossomos, que tem a sua capacidade de fusão com glicossomos e lisossomos reduzida. Além disso, parasitos ATG5 knockout, incapazes de formar autofagossomos foram cerca de 90% mais resistentes à morte induzida pelo AAG em relação a parasitos selvagens. Observamos, também, que o tratamento com MG132, um inibidor da atividade do proteassoma, assim como o 17-AAG induziu o acúmulo de proteínas ubiquitinadas de parasitos, especialmente em 8 parasitos incapazes de formar autofagossomos, sugerindo um papel da autofagia na degradação de proteínas ubiquitinadas. Por último, observamos que o MG132 foi capaz de induzir a formação de autofagossomos sugerindo uma ligação entre o acúmulo de proteínas ubiquitinadas e a indução da via autofágica. Em conjunto, nossos resultados indicam que o HSP90 é um alvo molecular que dever ser explorado no tratamento das leishmanioses. / Leishmaniases are endemic disease in Brazil caused by protozoan parasites from the genus Leishmania. Chemotherapy remains the most effective way of treatment and pentavalent antimonials, used for more than 70 years, remaining as first choice drugs for leishmaniasis treatment. The use of this and other drugs causes severe side effects, therapeutic regimens employed for leishmaniasis treatment are unpleasant, besides an increase number of resistance cases. The Heat Shock Protein 90 (HSP90) is a member of the chaperone family present in bacteria and eukaryotic cells. This protein is essential for the folding and stabilization of different proteins, known as client proteins. This chaperone has been considered an important molecular target for the treatment of different parasitic diseases. In this thesis, the specific inhibitors of the ATPase activity from the HSP90, 17-allylamino- 17-demethoxygeldanamycin (17-AAG), were tested against parasites from the genus Leishmania. First we evaluated its effect on axenic culture and observed that 17- AAG induces parasite cell death in lowerconcentrations than those needed to induce macrophage cell death. We also observed that 17-AAG intracellular parasite death in concentrations ranging from 25 to 500 nM after 24 or 48 h, being also able to kill amastigotes in latter times of infection, such as 96 h. The parasites die independently of the production of microbicide molecules, such as superoxide and nitric oxide, which had their production reduced by 61 and 58 %, respectively. 17- AAG treatment also reduced the production of pro-inflammatory molecules such as TNF-α, IL-6 e MCP-1 in 35, 35 and 98 %, respectively. Using the murine model of BALB/c mice infected with Leishmania braziliensis in the ear showed that treatment of 17-AAG reduces the size of the lesion in 0,5 mm and the parasite load in the ear in 25 %, however, the treatment wasn’t able to reduce the parasite load in the draining lymph node. Transmission electron microscopy analysis of infected macrophages treated with 17-AAG revealed alterations typical of autophagic process with cytoplasm vacuolization, formation of vacuoles with double membranes, besides the presence of myelin figures. Using transgenic parasites we observed that 17-AAG induces an increase of 35 % in the autophagosome formation witch have their ability to fuse with glycosome and lisosome reduced. However, in comparison to wild type parasites, ATG5 knockout parasites that are unable to form autophagosome were 90% more resistant to 17-AAG-induced cell death. We also observed that MG132 treatment, a proteasome inhibitor, like 17-AAG induced ubiquitined proteins accumulation in parasites, especially in parasites unable to form autophagosome, suggesting a role of autophagy in degradation of ubiquitinated proteins. Lastly, we observed that MG132 induced autophagosome formation, suggesting a link between ubiquitinated and induction of the autophagic pathway. In sum, our results indicate that HSP90 is a molecular target that should be explored as a treatment for leishmaniasis.

A leishmaniose é uma enfermidade infecciosa causada por várias espécies de parasitas do gênero Leishmania e representa um dos principais problemas de saúde pública nos países subdesenvolvidos. No hospedeiro, a sobrevivência do protozoário causador dessa doença depende de uma classe especial de proteínas, as chaperonas moleculares ou proteínas de choque térmico como também são conhecidas. A função dessas proteínas é auxiliar no processo de enovelamento protéico, no transporte de proteínas entre as membranas e em muitas outras importantes funções celulares. Neste processo, as chaperonas moleculares são auxiliadas pelas suas co-chaperonas que desempenham função de destaque. Dentre as principais famílias de chaperonas moleculares temos as Hsp70 e as Hsp90 com suas respectivas co-chaperonas, as Hsp40 e a Aha1. O presente trabalho pretendeu inicialmente expressar e purificar as co-chaperonas moleculares Hsp40I e Hsp40II de L. braziliensis para realizar estudos de caracterização estrutural por meio das técnicas de dicroísmo circular e fluorescência. Contudo, a insolubilidade dessas proteínas, que pode ter sido causada pela presença de mutações nas sequências de DNA, motivou a caracterização de outra co-chaperona, a Aha1 de L. braziliensis (LbAha1). A LbAha1 foi expressa no sobrenadante celular e purificada por três etapas cromatográficas (troca aniônica, afinidade por íons cálcio e gel filtração). A análise da sequência de aminoácidos dessa proteína mostra que ela possui 9 resíduos de triptofano distribuídos nos dois domínios característicos da LbAha1. Estudos de desnaturação química por uréia, monitorados pelas técnicas de dicroísmo circular e fluorescência, mostram que os dois domínios da LbAha1 apresentam estabilidades diferentes. Os estudos estruturais realizados permitiram identificar as transições com o respectivo domínio. / Leishmaniasis is an infectious disease caused by several species of Leishmania species and represents major public health problems in developing countries. In the harborer, the survival of the parasite that cause this disease depends on a special class of proteins, molecular chaperones or heat shock proteins as they are also known. The function of these proteins is to assist in protein folding, transport of proteins and many other important cellular functions. In this process the molecular chaperones are helped by their co-chaperones that play a prominent role. Among the main families of molecular chaperones, there are Hsp70 and Hsp90 with their respective co-chaperones, Hsp40 and the Aha1. The present work, initially pretended to express and purify the molecular co-chaperones Hsp40I and Hsp40II of the L. braziliensis for structural characterization by spectroscopic techniques like fluorescence and circular dichroism. However, the insolubility of these proteins, possibly caused by the presence of mutations in their DNA sequences, led to the characterization of another co-chaperone, the Aha1 of the L. braziliensis. These proteins were expressed in the cell supernatant and purified by three chromatographic steps (anion exchange, affinity for calcium ions and gel filtration). The analysis of the DNA sequence of this protein shows that it has nine Trp residues distributed between the two domains and by urea denaturation studies monitored by fluorescence techniques and circular dichroism show that they have different stabilities.

Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2017-07-12T19:09:00Z No. of bitstreams: 1 2015 - Daiana de Fatima Portella Franco.pdf: 10785257 bytes, checksum: 88b5e7659327980d96446ec26df23a79 (MD5) / Made available in DSpace on 2017-07-12T19:09:00Z (GMT). No. of bitstreams: 1 2015 - Daiana de Fatima Portella Franco.pdf: 10785257 bytes, checksum: 88b5e7659327980d96446ec26df23a79 (MD5) Previous issue date: 2015-08-27 / CAPES / CNPq / FAPERJ / Cancer is a generic term related to more than 100 types of diseases which resemble each other by their disorganized cellular growth. HSP90 are ATP-dependent chaperones responsible for the activation and stabilization of more than 200 proteins. Most of these proteins are connected to cancer and need HSP90 to execute their activities. Thus, HSP90 inhibitors may indirect inhibit plenty oncogenic proteins. According to the literature, there are N-terminal and C-terminal domains, nevertheless, C-terminal inhibitors present more advantages. Then, the advancement of C-terminal inhibitors represents an applicable alternative and an intense field of study. Novobiocin is the first compound identified as C-terminal domain inhibitor. Nowadays, Novobiocin analogues have been synthesized, besides its structure-activity relationship elucidated in order to develop more potents analogues. For that reason, the goal of this project is to obtain 2 analogue series of Novobiocin. The scheme of these series was based on maintaining the coumaniric part presented on Novobiocin: isosteric replacement of the amide group that binds coumarin to the 4-hydroxy-3-(3-methylbut-2-yl)-benzamide, by the [1,2,3]-triazole; and exploration of methyl groups (AN1) and hydroxyl (AN2) in substitution of subunit noviose. AN1 series (76a-g) and AN2 (77a-g) were synthesized from the followed reactions: 7-hydroxy-coumarine o-methylation (83); 7-methoxy-coumarine 3-bromation (82); Sonogashira cross-coupling from 3-bromo-7-R-coumarine (81a-b); 7-R-3-((trimethylsilyl)ethynyl-coumarine trimethylsilyl deprotection (88a-b); and lastly, synthesis of the triazole ring, through cicloaddition reaction, 1,3-dipolar catalysed by copper (CuAAc), using 3-ethynyl-7-R-coumarine (80a-b) and aromatic azides. It is worth taking into consideration that 3-bromo-7-R-coumarine (81b) was obtained from the key compound, 3-bromo-7-R-methoxy-coumarine (81a) by o-demethylation reaction. 12 compounds were obtained (76a-g) and 8 of them (76a-b, 77d) were nicely purified and then, characterized by spectroscopic techniques (IR, 1H and 13C NMR). The ?one-pot? synthesis of 7-methoxy-3-(1H-1,2,3-triazole-4-phenyl)-coumarine 76b from 88a compound (Yield=86%) was more efficient than the one realized in two steps (global yield=47,2%). Results are potential and satisfactory, moreover there is no citation in any literature about biological activities of the synthesized compounds. Continuing this work, the pure compounds (76a-b, 77d) will be tested on breast cancer cell lines SkBr3 and MCF-7. / O c?ncer ? um termo gen?rico que se refere a um conjunto de mais de 100 tipos de doen?as, as quais se assemelham pelo crescimento celular desordenado. As HSP90 s?o chaperonas ATP-dependente respons?veis pela ativa??o e estabiliza??o de mais de 200 prote?nas. Muitas destas prote?nas s?o relacionadas ao c?ncer e necessitam da HSP90 para exercerem suas atividades. Assim, inibidores da HSP90 s?o promissores, pois possibilitam inibir de maneira indireta v?rias prote?nas oncog?nicas simultaneamente. S?o descritos inibidores dos dom?nios N-terminal e C-terminal, sendo estes mais vantajoso que aqueles. O Novobiocin foi o primeiro composto identificado como inibidor do dom?nio C-terminal da HSP90. Atualmente, diversos an?logos ao Novobiocin tem sido sintetizados, afim de se estabelecer a rela??o estrutura-atividade, objetivando desenvolver an?logos mais potentes. Assim, o objetivo deste trabalho foi obter duas s?ries an?logas ao Novobiocin. O planejamento das s?ries foi baseado na manuten??o do n?cleo cumar?nico presente no Novobiocin; troca isost?rica do grupo amida, que liga a cumarina ao anel 4-hidroxi-3-(3-metillbut-2-il)-benzamida, pelo anel [1,2,3]-triazol; e explora??o de grupos metoxila (AN1) e hidroxila (AN2) em substitui??o ? subunidade noviose. As s?ries AN1 (76a-g) e AN2 (77a-g) foram sintetizadas a partir das rea??es de: O-metila??o da 7-hidroxi-cumarina (83); broma??o da posi??o 3 da 7-met?xi-cumarina (82); rea??o de acoplamento cruzado de Sonogashira, a partir da 3-bromo-7-R-cumarina (81a-b); desprote??o do grupamento trimetilsilila da 7-R-3-((trimetilsilil)etenil)-cumarina (88a-b); e por fim, s?ntese do anel triaz?lico, atrav?s da rea??o de cicloadi??o 1,3-dipolar catalisada por cobre (CuAAc), utilizando 3-etenil-7-R-cumarina (80a-b) e azidas arom?ticas. Vale ressaltar que, a 3-bromo-7-hidr?xi-cumarina (81b) foi obtida a partir do composto chave, 3-bromo-7-met?xi-cumarina (81a) via rea??o de O-demetila??o. Obteve-se 12 compostos (76a-g e 77a-g) sendo que 8 (76a-b, 77d) foram, satisfatoriamente, purificados e, ent?o, caracterizados por t?cnicas espectrosc?picas (IV, RMN H e C). Tamb?m foi constatado que a s?ntese ?one-pot? de 7-metoxi-3-(1H-1,2,3-triazol-4-fenil)-cumarina 76b partir do composto 88a (R=86%) foi mais eficiente que a realizada em duas etapas, desilina??o/CuAAc (Rglobal= 47,2%). Os resultados s?o satisfat?rios e promissores, al?m disso n?o h? na literatura descri??o das atividades biol?gica dos compostos sintetizados. Em continua??o a este trabalho, os compostos puros (76a-b, 77d) ser?o devidamente ensaiados frente a c?lulas das linhagens de c?ncer de mama SkBr3 e MCF-7.

L’ordre viral des Mononegavirales contient de nombreux virus pathogènes tels que le virus de la rougeole, le virus de la rage, le virus des oreillons ou encore le virus Ebola. Ces virus mettent tous en place des mécanismes moléculaires similaires, notamment concernant la synthèse des ARN viraux. Le complexe polymérase, composé de la polymérase virale (L) et de la phosphoprotéine (P), possède un fonctionnement encore obscur et unique dans le monde du vivant, notamment car il utilise une matrice enchâssée dans une gaine protéique. La formation de ce complexe a été étudiée et la protéine chaperon HSP90 (« Heat Shock Protein of 90 kD ») s’est révélée nécessaire à la formation du complexe. L’inhibition de l’activité d’HSP90 entraine l’ubiquitination et la dégradation de la protéine L par le protéasome. Les protéines P et HSP90 sont toutes les deux nécessaires au repliement de la protéine L et à la formation d’un complexe P-L stable, soluble et fonctionnel. Les domaines de P impliqués dans la formation du complexe, ont également été cartographiés et révèlent des interactions complexes entre P et L, mêlant liaison, stabilisation, repliement et fonction. Enfin, une interaction entre P et la protéine virale C, connue pour inhiber la synthèse des ARN viraux, a été identifiée, cartographiée et ouvre des perspectives quant aux mécanismes moléculaires sous-jacents à son effet inhibiteur. / The Mononegavirales order contains several pathogens like measles, rabies, mumps and Ebola viruses. These viruses share numerous homologous molecular mechanisms and in particular they have a highly conserved RNA synthesis machinery that is unique in the living world. Indeed, the polymerase complex, composed of the polymerase (L) and the phosphoprotein (P), uses a template of RNA recovered by a sheath made of nucleoproteins. The formation of the complex was investigated and the chaperone protein HSP90 (Heat Shock Protein of 90 kD) was shown to be required for the formation of the complex. The inhibition of HSP90 activity induces the ubiquitinylation and the degradation of the L protein by the proteasome. Both P and HSP90 are required to form stable, soluble and functional polymerase complexes. The domains of P involved in the formation of the complex have been mapped and they show that the interplay between P and L is complex with at least three identified functions: binding, folding and function of the polymerase complex. Finally, an interaction between P and the viral C protein, known to inhibit the viral RNA synthesis, have been identified, mapped and allows new perspectives concerning the molecular mechanism underlying its inhibitory effect.

Hsp90 (heat shock protein 90) est une protéine chaperonne ubiquitaire et conservée impliquée dans le repliement et la réparation de protéines dites « clientes ». Parmi ces protéines, de nombreuses sont impliquées dans des phénomènes oncogéniques, faisant de hsp90 une cible d’intérêt dans le traitement du cancer. Hsp90 est constituée de trois domaines, un domaine N-terminal site de l’hydrolyse de l’ATP, nécessaire à sa fonction ; un domaine intermédiaire où vient se fixer la protéine cliente et un domaine C-terminal impliqué dans la dimérisation, étape indispensable pour le repliement de la protéine cliente. De nombreux inhibiteurs ont été synthétisés en ciblant ces différents domaines. Les inhibiteurs N-terminaux sont efficaces, à l’instar de la Geldanamycine en termes d’activité anti-tumorale mais des effets secondaires ainsi que des résistances au traitement ont limité leur utilisation en pratique clinique. En effet, l’inhibition N-terminale induit une réponse au stress caractérisée par une augmentation de hsp90 et de ses co-chaperonnes, souvent associée à une résistance au traitement et un pronostic défavorable. La novobiocine, un antibiotique coumarinique, est capable d’inhiber le domaine C-terminal de hsp90, sans induire de réponse au stress. Ainsi de nombreux dérivés de cette molécule ont été synthétisés, parmi lesquels on trouve le 6BrCaQ. Cette molécule induit l’apoptose et le blocage dans le cycle cellulaire sur plusieurs lignées cellulaires (dont MCF-7 et MDA-MB-231) et provoque la dégradation de plusieurs protéines clientes impliquées dans le développement tumoral mais sa faible solubilité limite son administration in vivo.Dans cette thèse, une forme liposomale du 6BrCaQ a été développée et étudiée sur des lignées cellulaires de cancer de prostate, de sein et de leucémie aigüe myéloïde in vitro et in vivo sur un modèle orthotopique de cancer du sein (MDA-MB-231 luc-GFP). Le 6BrCaQ liposomal est capable d’ induire de l’apoptose, de bloquer le cycle cellulaire sur différentes lignées cellulaires (PC-3, MDA-MB-231 et MOLM-13) mais également de ralentir la migration cellulaire sur PC-3 (test de comblement de blessure). De plus, le 6BrCaQ liposomal entre en synergie avec la doxorubicine (cellules PC-3) et la daunorubicine (cellules MOLM-13). Au niveau moléculaire, les liposomes de 6BrCaQ modifient l’expression protéique de Hsp90 sans modifier celle d’Hsp70 sur PC-3 alors que les gènes codant pour les Hsp70 semblent être légèrement induits dans MDA-MB-231. Les résultats in vivo ont montré un ralentissement de la croissance tumorale sur un modèle de cancer du sein orthotopique (MDA-MB-231-luc2-GFP) dès 13 jours de traitement pour une dose de 1 mg/kg injectée une fois par semaine. Des analyses histologiques ont révélé une augmentation de la proportion des zones nécrotiques dans le groupe traité par rapport au contrôle et une diminution significative de la prolifération cellulaire (marquage au KI67) intra-tumorale.Par ailleurs, Hsp90 possède également des isoformes et des analogues localisés dans des organites intracellulaires, parmi lesquelles, TRAP-1, localisée au niveau de la mitochondrie, impliquée dans la rgulation du métabolisme mitochondrial et qui pourrait jouer un rôle dans la progression tumorale et les métastases. Le déqualinium (DQ) est capable de cibler la mitochondrie. Dans une seconde partie du travail, des liposomes encapsulant le DQ ont été formulés dans le but de vectoriser le 6BrCaQ vers la mitochondrie. Toutefois, face à la difficulté d’encapsuler le DQ dans des liposomes, une étude de physico-chimie sur l’interaction DQ/liposomes a été mise en place pour comprendre comment le DQ agit sur les bicouches phospholipidiques. Cette étude a révélé que, malgré une capacité de ciblage mitochondrial des liposomes, le DQ était difficile à encapsuler dans les milieux salins et n’était pas inerte sur les bicouches lipidiques ce qui limite son utilisation pour la formulation de liposomes ciblant la mitochondrie. / Hsp90 (Heat shock protein 90) is an ubiquitous and well-conserved chaperone protein involved in the folding and the repair of « client » proteins. Among these proteins, several are involved in oncogenic phenomena making hsp90 an interesting target for cancer therapy. Hsp90 consists of three domains ; a N-terminal domain as the ATP hydrolysis site ; a middle domain where the client proteins binds and a C-terminal domain involved in the dimerization, a necessary step to refold the client protein. Several inhibitors were synthesized to target these different domains. N-terminal inhibitors such as Geldanamycin ; were shown to be very efficient but side effects and resistance to the treatment limited their clinical use. Indeed, N-terminal inhibition induces a stress response characterized by an increase of hsp90 and its co-chaperones which is often associated with resistance to the treatment and poor prognosis. Novobiocin, a coumarin antibiotic, is capable of inhibiting the C-terminal domain of hsp90, without inducing a stress response. Several derivatives of this molecule have been synthesized, including 6BrCaQ. The latter was effective in terms of apoptosis induction and cell cycle blockade on several cell lines (MCF-7, MDA-MB-231) and induced pro-tumoral client protein degradation but its low solubility limits its in vivo administration. In this thesis, a liposomal formulation of 6BrCaQ has been developed and studied on in prostate cancer cell lines and acute myelogenous leukemia in vitro and in vivo in an orthotopic model of breast cancer (MDA-MB-231 luc-GFP). Liposomal 6BrCaQ showed ability to induce apoptosis, to block the cell cycle on several cell lines (PC-3 and MDA-MB-231) and slow down migration of PC-3 cells (wound healing assay). Liposomal 6BrCaQ is able to synergize with doxorubicine or daunorubicine in PC-3 cells and in MOLM-13 cells, respectively. Moreover, protein and RNA expression profiles show that in PC-3 cells liposomal 6BrCaQ downregulates Hsp90 protein and in MDA-MB-231 cells slightly upregulates Hsp70 gene expression. Results obtained during in vivo experiments on the breast orthotopic model revealed a slow downslowdown of tumor growth after 13 days for a dose of 1 mg/kg injected weekly. Histological analysis revealed necrosis in treated groups and aassociated with a decreased cell proliferation (ki67 staining).Hsp90 also has isoforms and analogues localized in intracellular organelles, including, TRAP-1, localized in the mitochondrion and probably implicated in malignant progression through its role in the regulation of the mitochondrial metabolism. Dequalinium (DQ) demonstrated ability to target the mitochondrion. In a second part of the work, liposomes encapsulating DQ have been formulated in order to target 6BrCaQ to mitochondria. However, faced with the difficulty of encapsulating the DQ in liposomes, a physical chemistry study on the interaction DQ / liposomes was established to understand how DQ acts on phospholipid bilayers. Though a mitochondrial targeting capacity, this study revealed DQ was difficult to encapsulate in liposomes in saline medium and not completely inert on lipid bilayers limiting its use to target liposomes to mitochondria.

La protéine chaperon HSP90 a de nombreux substrats par les voies de signalisations. Son inhibition engendre un effet tumoral. L'identification du complexe R2TP,un nouveau cochaperon d'HSP90, a mis en évidence de nouveaux substrats. Le système HSP90/R2TP est impliqué dans l'assemblage de complexes macromoléculaires ( PIKKs, Télomérase RNP, ARN polyméras, snoRNP) jouant un rôle clé dans la prolifération cellulaire et la tumorigénèse. Le R2TP est composé de 4 protéines : RUVBL1, RUVBL2, RPAP3 et PIH1D1 dont certains sont surexprimés dans les cancers hépatocellulaires ou colorectaux. Afin d'étudier le rôle du R2TP dans l'homéostasie intestinale et la carcinogénèse, nous avons généré un modèle d'invalidation de RPAP3 chez la souris. L'invalidation de RPAP3 dans l'organisme entier est létale. Son invalidation à l'âge adulte uniquement dans l'intestin entraine une phénotype sévère en 8jours aboutissant à la mort des individus à 10jours. En parallèle, nous avons étudié le rôle potentiel de RPAP3 dans la tumorigénèse intestinale et colorectale avec deux modèles d'induction , génétique avec l'invalidation du gène APC et chimique avec le protocole AOM/DSS. / Many substrates of HSP90 are involved in signal transduction pathways and related to tumour progression. Inhibition of HSP90 has anti-tumoral effects. Identification of the R2TP, a new HSP90 co-chaperon, allowed the identification of a new set of HSP90 substrates. HSP90/R2TP is involved in the assembly of snoRNPs, telomerase RNP, the nuclear RNA polymerases and PIKKs, which play key functions in cellular proliferation and tumorigenesis. R2TP is formed of four proteins: RUVBL1, RUVBL2, PIH1D1 and RPAP3, some of which are overexpressed in hepatocellular and colorectal cancer. We thus hypothesize that the co-chaperone R2TP could be involved in colorectal carcinogenesis.To study the role of R2TP in intestinal homeostasis and carcinogenesis, we generated a conditional knock-out murine model for RPAP3. We showed that RPAP3 invalidation in whole organism or only in colon is lethal at embryonic stage. The invalidation of RPAP3 in adult intestine, using an inducible recombinase (RPAP3 fl; Villin>Cre-ERT2), leads to a drastic phenotype as soon as 8 days post-induction, resulting in death after 10 days. This phenotype is reminiscent of proliferative defects.In parallel, we address the possibility of a therapeutic window to target RPAP3 during intestinal tumorigenesis by using heterozygous animals (RPAP3 fl/+; Villin>Cre-ERT2 ) in which tumorignesis is induced (i) either by a chemical treatment : for this, we take advantage of the established AOM /DSS protocol, or, (ii) by a genetic one ( Apc LoxP/+).These ongoing experiments will address the role of R2TP in a tissue with a constant turnover and the relevance of R2TP in tumorigenesis.